Regulation of F-box proteins by noncoding RNAs in human cancers

被引:30
作者
Lin, Min [1 ]
Xu, Yichi [1 ]
Gao, Ying [1 ]
Pan, Chunyu [1 ]
Zhu, Xuegiong [1 ]
Wang, Zhi-Wei [1 ,2 ,3 ]
机构
[1] Wenzhou Med Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, 109 Xueyuan Xi Rd, Wenzhou 325027, Zhejiang, Peoples R China
[2] Bengbu Med Coll, Sch Lab Med, Dept Biochem & Mol Biol, Bengbu 233030, Anhui, Peoples R China
[3] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA
关键词
Ubiquitinatlon; FBXW7; beta-TrCP; Skp2; MiRNA; CELL LUNG-CANCER; HUMAN GASTRIC-CANCER; EPITHELIAL-MESENCHYMAL TRANSITION; UBIQUITIN-PROTEASOME SYSTEM; LNCRNA MT1JP FUNCTIONS; TUMOR-SUPPRESSOR; MESSENGER-RNA; UP-REGULATION; HEPATOCELLULAR-CARCINOMA; INHIBITS PROLIFERATION;
D O I
10.1016/j.canlet.2019.09.008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
F-box proteins (FBPs) are proteins containing an F-box domain and are one of three subunits in SKP1-Cullinl-F-box protein (SCF) E3 ligase complexes. Accumulated evidence has shown that FBP regulates tumorigenesis and the progression of human cancer via ubiquitination and degradation of downstream substrates, which can be oncoproteins or tumor suppressors. Emerging evidence has revealed that noncoding RNAs (ncRNAs) govern the expression of FBP in human cancers. Specifically, microRNAs (miRNAs), long ncRNAs (lncRNAs), and circular RNAs (circRNAs) have been shown to govern FBP expression in malignancies. Therefore, in this review article, we discuss how miRNAs target FBPs and participate in tumorigenesis and tumor progression. Moreover, we briefly highlight the role of lncRNAs and circRNAs in the regulation of FBPs in cancer. Therefore, targeting ncRNAs could be a novel approach to regulate FBPs for anticancer therapy.
引用
收藏
页码:61 / 70
页数:10
相关论文
共 179 条
[1]   FBXO11 promotes the neddylation of p53 and inhibits its transcriptional activity [J].
Abida, Wassim M. ;
Nikolaev, Anatoly ;
Zhao, Wenhui ;
Zhang, Wenzhu ;
Gu, Wei .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (03) :1797-1804
[2]   MicroRNA in Cancer and Cachexia-A Mini-Review [J].
Acunzo, Mario ;
Croce, Carlo M. .
JOURNAL OF INFECTIOUS DISEASES, 2015, 212 :S74-S77
[3]   Clinical utility of circulating non-coding RNAs - an update [J].
Anfossi, Simone ;
Babayan, Anna ;
Pantel, Klaus ;
Calin, George A. .
NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (09) :541-563
[4]  
[Anonymous], 2018, MEDICINE, DOI DOI 10.1097/MD.0000000000010394
[5]   CircRNAs and cancer: Biomarkers and master regulators [J].
Arnaiz, Esther ;
Sole, Carla ;
Manterola, Lorea ;
Iparraguirre, Leire ;
Otaegui, David ;
Lawrie, Charles H. .
SEMINARS IN CANCER BIOLOGY, 2019, 58 :90-99
[6]   SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box [J].
Bai, C ;
Sen, P ;
Hofmann, K ;
Ma, L ;
Goebl, M ;
Harper, JW ;
Elledge, SJ .
CELL, 1996, 86 (02) :263-274
[7]   Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets [J].
Bedford, Lynn ;
Lowe, James ;
Dick, Lawrence R. ;
Mayer, R. John ;
Brownell, James E. .
NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (01) :29-46
[8]  
Bhat Shakil Ahmad, 2016, Noncoding RNA Res, V1, P43, DOI 10.1016/j.ncrna.2016.11.002
[9]   A network-biology perspective of microRNA function and dysfunction in cancer [J].
Bracken, Cameron P. ;
Scott, Hamish S. ;
Goodall, Gregory J. .
NATURE REVIEWS GENETICS, 2016, 17 (12) :719-732
[10]   miR-1297 Promotes Cell Proliferation of Non-Small Cell Lung Cancer Cells: Involving in PTEN/Akt/Skp2 Signaling Pathway [J].
Bu, Wenjin ;
Luo, Tianyou .
DNA AND CELL BIOLOGY, 2017, 36 (11) :976-982